Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2012 | $5,602 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2012 | $12,443 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2012 | $13,576 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2012 | $15,915 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2012 | $16,858 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2012 | $20,827 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2012 | $32,718 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2012 | $54,345 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $65,595 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | North Carolina | state | 2012 | $98,209 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $112,006 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2012 | $169,007 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2012 | $218,644 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2012 | $296,213 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2012 | $607,213 | | tax credit/rebate |
GlaxoSmithKline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2012 | $4,025,543 | | tax credit/rebate |
Novo Nordisk | Novo Holdings A/S | North Carolina | state | 1992 | $141,554 | | grant |
Embrex, Inc. | Pfizer | North Carolina | state | 2003 | $65,000 | | grant |
Wyeth-Lederle (#2) | Pfizer | North Carolina | state | 2004 | $500,000 | | grant |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $4,414,142 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $1,077,666 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2013 | $755,362 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2013 | $547,098 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2013 | $338,906 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $272,967 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $201,061 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2013 | $154,920 | | tax credit/rebate |
Pharmacia Corporation | Pfizer | North Carolina | state | 2013 | $145,378 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $115,708 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2013 | $108,155 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $85,010 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2013 | $57,596 | | tax credit/rebate |
Valeant Pharmaceuticals International | Bausch Health | North Carolina | state | 2013 | $47,287 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2013 | $42,180 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2013 | $37,544 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2013 | $31,549 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2013 | $29,917 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2013 | $19,136 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2013 | $17,655 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2013 | $13,505 | | tax credit/rebate |
Pozen, Inc. | Miravo Healthcare | North Carolina | state | 2013 | $13,254 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2013 | $8,044 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2013 | $7,359 | | tax credit/rebate |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $5,646 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2013 | $4,011 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2013 | $2,237 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2013 | $2,120 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2013 | $1,816 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2013 | $1,058 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2013 | $1,230,023 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $955,302 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $816,254 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2013 | $645,885 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $261,281 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $250,478 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2013 | $27,212 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $14,625 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $8,650 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2013 | $6,107 | | tax credit/rebate |
Novo Nordisk Biochem | Novo Holdings A/S | North Carolina | state | 1994 | $75,000 | | grant |
Biogen | Biogen | North Carolina | state | 1995 | $120,000 | | grant |
Merck & Co., Inc. | Merck | North Carolina | state | 1999 | $67,000 | | grant |
Merck & Co., Inc. | Merck | North Carolina | state | 2001 | $33,000 | | grant |
Embrex, Inc. | Pfizer | North Carolina | state | 2003 | $9,228 | | grant |
Abbott Laboratories | Abbott Laboratories | North Carolina | state | 2003 | $50,000 | | grant |
Embrex, Inc. | Pfizer | North Carolina | state | 2005 | $30,772 | | grant |
Novo Nordisk | Novo Holdings A/S | North Carolina | state | 2007 | $125,000 | | grant |
Sandoz (Eon) | Sandoz Group | North Carolina | state | 2008 | $150,000 | | grant |
Eisai, Inc. | Eisai | North Carolina | state | 2009 | $150,000 | | grant |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2009 | $750,000 | | grant |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2010 | $2,250,000 | | grant |
United Therapeutics | United Therapeutics | North Carolina | state | 2012 | $155,750 | | grant |
Novo Nordisk Pharmaceutical Industr | Novo Holdings A/S | North Carolina | state | 2012 | $288,000 | | grant |
Novo Nordisk Pharmaceutical Industr | Novo Holdings A/S | North Carolina | state | 2013 | $65,000 | | grant |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $483,750 | | grant |
Novartis Vaccines & Diagnostics, Inc | Novartis | North Carolina | state | 2014 | $653,000 | | grant |
Novartis Vaccines & Diagnostics, Inc | Novartis | North Carolina | state | 2014 | $347,000 | | grant |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $4,097,786 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $687,362 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $231,735 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $167,753 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $147,230 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $72,693 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $63,148 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2013 | $44,364 | | tax credit/rebate |
Eon Labs, Inc. | Novartis | North Carolina | state | 2013 | $43,359 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2013 | $29,864 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2013 | $7,529 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $3,476,438 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $645,884 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $185,492 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $97,337 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $59,897 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2014 | $19,526 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2014 | $29,864 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $162,504 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $218,428 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $253,035 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $143,193 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $126,863 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $117,680 | | tax credit/rebate |